Familial HDL deficiency characterized by hypercatabolism of mature apoA- I but not proApoA-I

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 4, 1998, Pages 655-664

  Batal, Rami ^b   Tremblay, Michel ^b   Krimbou, Larbi ^b   Marner, Orval ^c   Davignon, Jean ^b   Genest Jr , Jacques ^a   Cohn, Jeffrey S ^b  

^a Hyperlipidemia and Atherosclerosis Research Group   (Canada)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Atherosclerosis; Cholesterol; Hypoalphalipoproteinemia; Kinetics; Reverse cholesterol transport

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; HUMAN; LIPOLYSIS; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; TANGIER DISEASE;

EID: 0031956778     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.4.655     Document Type: Article

References (25)

1. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med. 1991;325:373-381.
2. Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham study. JAMA. 1986;256:2835-2838.
3. Eisenberg S. High density lipoprotein metabolism. J Lipid Res. 1984;25:1017-1058.
4. Parthasarathy S, Barnett J, Fong LG. High density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta. 1990;1044:275-283.
5. Cockerill GW, Rye K-A, Gamble JR, Vadas MA, Barter PJ. High density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Aeterioscler Thromb Vasc Biol. 1995;15:1987-1994.
6. Riddell DR, Graham A, Owen JS. Apolipoprotein E inhibits platelet aggregation through the L-arginine:nitric oxide pathway: implication for vascular disease. J Biol Chem. 1997;272:1:89-95.
7. Law SW, Gray G, Brewer HB Jr. DNA cloning of human apoA-I: amino acid sequences of preproapoA-I. Biochem Biophys Res Commun. 1983;112:257-264.
8. Edelstein C, Gordon JI, Toscas K, Sims HF, Strauss AW, Scanu AM. In vitro conversion of proapoprotein A-I to apoprotein A-I. J Biol Chem. 1983;258:19:11430-11433.
9. Horowitz BS, Goldberg IJ, Merab J, Vanni TM, Ramakrishnan R, Ginsberg HN. Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol. J Clin Invest. 1993;91:1743-1752.
10. Eggerman TL, Hoeg JM, Meng MS, Bojanovski D, Brewer HB Jr. Differential tissue-specific expression of human apoA-I and apoA-II. J Lipid Res. 1991;32:821-828.
11. Gordon JI, Budelier KA, Sims HF, Edelstein C, Scanu AM, Strauss AW. Biosynthesis of human preproapolipoprotein A-II. J Biol Chem. 1983;258:22:14054-14059.
12. Cheung MC, Albers JJ. Characterization of lipoprotein particles isolated by immunoaffmity chromatography: particles containing A-I and A-II and particles containing A-I but no A-II. J Biol Chem. 1984;259:12201-12209.
13. Fidge N, Nestel P, Ishikawa T, Reardon M, Billington T. Turnover of apoproteins A-I and A-II of high density lipoprotein and the relationship to other lipoproteins in normal and hyperlipidemic individuals. Metabolism. 1980;29:643-653.
14. Schaefer EJ, Zech LA, Jenkins LL, Bronzert TJ, Rubalcaba EA, Lindgren RT, Aamodt RL, Brewer HB Jr. Human apolipoprotein A-I and A-II metabolism. J Lipid Res. 1982;23:850-862.
15. Ikewaki K, Zech LA, Kindt M, Brewer HB Jr, Rader DJ. Apolipoprotein A-II production rate is a major factor regulating the distribution of apolipoprotein A-I among HDL subclasses LpA-I and LpA-I:A-II in normolipidemic humans. Arterioscler Thromb Vasc Biol. 1994;14:306-312.
16. Brinton EA, Eisenberg S, Breslow JL. Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size: effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution. Arterioscler Thromb Vasc Biol. 1994;14:707-720.
17. Genest J Jr, Bard J, Fruchart J, Ordovas JM, Schaefer EJ. Familial hypoalphalipoproteinemia in premature coronary artery disease. Arterioscler Thromb Vasc Biol. 1993;13:1728-1737.
18. Rader DJ, Ikewaki K. Unraveling high density lipoprotein-apolipoprotein metabolism in human mutants and animal models. Curr Opin Lipidol. 1996;7:117-123.
19. Assmann G, Funke H. HDL metabolism and atherosclerosis. J Cardiovasc Pharmacol. 1990;16(suppl 9):S15-S20.
20. Francis GA., Knopp RH, Oram JF. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease. J Clin Invest. 1995;96:78-87.
21. Rogler G, Trümbach B, Klima B, Lackner KJ, Schmitz G. HDL-mediated efflux of intracellular cholesterol is impaired in fibroblasts from Tangier disease patients. Arterioscler Thromb Vasc Biol. 1995;15:683-690.
22. 1,-HDL and conversion into α-HDL: evidence for disturbed HDL conversion in Tangier disease. Arterioscler Thromb Vasc Biol. 1995;15:1746-1754.
23. Marcil M, Boucher B, Krimbou L, Solymoss BC, Davignon J, Frohlich J, Genest J Jr. Severe familial HDL deficiency in French-Canadian kindreds. Arterioscler Thromb Vasc Biol. 1995;15:1015-1024.
24. Minnich A, Kessling A, Roy M, Giry C, DeLangavant G, Lavigne J, Lussier-Cacan S, Davignon J. Prevalence of alleles encoding defective lipoprotein lipase in hypertriglyceridemic patients of French Canadian descent. J Lipid Res. 1994;36:117-124.
25. Schaefer EJ, Blum CB, Levy RI, Jenkins LL, Alaupovic P, Foster DM, Brewer HB Jr. Metabolism of high-density lipoprotein apolipoproteins in Tangier disease. N Engl J Med. 1978;299:905-910.